BRPI0908128A2 - Método para isolamento de ácido nucleicos apoptóticos ou fetais livres de células - Google Patents

Método para isolamento de ácido nucleicos apoptóticos ou fetais livres de células

Info

Publication number
BRPI0908128A2
BRPI0908128A2 BRPI0908128-3A BRPI0908128A BRPI0908128A2 BR PI0908128 A2 BRPI0908128 A2 BR PI0908128A2 BR PI0908128 A BRPI0908128 A BR PI0908128A BR PI0908128 A2 BRPI0908128 A2 BR PI0908128A2
Authority
BR
Brazil
Prior art keywords
isolation
nucleic acids
cell free
fetal nucleic
free apoptotic
Prior art date
Application number
BRPI0908128-3A
Other languages
English (en)
Inventor
Ram Bhatt
Wen-Hua Fan
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0908128A2 publication Critical patent/BRPI0908128A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
BRPI0908128-3A 2008-02-12 2009-02-06 Método para isolamento de ácido nucleicos apoptóticos ou fetais livres de células BRPI0908128A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2806408P 2008-02-12 2008-02-12
PCT/US2009/033375 WO2009102632A2 (en) 2008-02-12 2009-02-06 Method for isolating cell free apoptotic or fetal nucleic acids

Publications (1)

Publication Number Publication Date
BRPI0908128A2 true BRPI0908128A2 (pt) 2015-08-04

Family

ID=40957453

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908128-3A BRPI0908128A2 (pt) 2008-02-12 2009-02-06 Método para isolamento de ácido nucleicos apoptóticos ou fetais livres de células

Country Status (8)

Country Link
US (1) US20110171640A1 (pt)
EP (1) EP2242857A4 (pt)
JP (1) JP2011511644A (pt)
CN (1) CN101999003A (pt)
BR (1) BRPI0908128A2 (pt)
CA (1) CA2714212A1 (pt)
MX (1) MX2010008820A (pt)
WO (1) WO2009102632A2 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010121294A1 (en) 2009-04-21 2010-10-28 Genetic Technologies Limited Methods for obtaining fetal genetic material
CA2817990A1 (en) * 2009-12-23 2011-06-30 Genetic Technologies Limited Methods of enriching and detecting fetal nucleic acids
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
US10533223B2 (en) 2010-08-06 2020-01-14 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US11203786B2 (en) 2010-08-06 2021-12-21 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US20120034603A1 (en) * 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US11031095B2 (en) 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US11270781B2 (en) 2011-01-25 2022-03-08 Ariosa Diagnostics, Inc. Statistical analysis for non-invasive sex chromosome aneuploidy determination
WO2012129363A2 (en) 2011-03-24 2012-09-27 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
CN113355321A (zh) 2011-09-26 2021-09-07 凯杰有限公司 用于分离细胞外核酸的快速方法
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
EP2875156A4 (en) 2012-07-19 2016-02-24 Ariosa Diagnostics Inc SEQUENTIAL LIGATION-BASED MULTIPLEX DETECTION OF GENETIC VARIANTS
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
CN104781421B (zh) 2012-09-04 2020-06-05 夸登特健康公司 检测稀有突变和拷贝数变异的系统和方法
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
CN105378108A (zh) * 2013-03-13 2016-03-02 雅培分子公司 用于分离核酸的系统和方法
ES2660989T3 (es) 2013-12-28 2018-03-27 Guardant Health, Inc. Métodos y sistemas para detectar variantes genéticas
EP3136096B1 (en) * 2014-04-23 2021-12-01 Nichirei Biosciences Inc. Combination for target marker detection
JP6787916B2 (ja) 2015-06-10 2020-11-18 キアゲン ゲーエムベーハー アニオン交換粒子を使用する細胞外核酸を単離する方法
SG11201805119QA (en) 2015-12-17 2018-07-30 Guardant Health Inc Methods to determine tumor gene copy number by analysis of cell-free dna
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
EP3461274B1 (en) 2016-09-30 2020-11-04 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
CN110133271B (zh) * 2018-02-09 2022-12-13 北京豪迈生物工程股份有限公司 一种将抗体或其抗原结合片段共价结合至颗粒表面的方法
CN109342718A (zh) * 2018-09-29 2019-02-15 宁波奥丞生物科技有限公司 一种磁微粒化学发光检测方法
WO2020160414A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
US12612615B2 (en) 2019-04-26 2026-04-28 Thermo Fisher Scientific Baltics, UAB Isolated nucleic acid binding domains
AU2021345359A1 (en) * 2020-09-21 2023-05-11 Enumera Molecular, Inc. Compositions and methods for isolation of cell-free dna

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978608A (en) * 1987-09-04 1990-12-18 Molecular Devices Corporation DNA detection system
US4963658A (en) * 1987-09-04 1990-10-16 Molecular Devices Corporation DNA detection method
US6630301B1 (en) * 1997-03-14 2003-10-07 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
GB9704444D0 (en) * 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
GB9709728D0 (en) * 1997-05-13 1997-07-02 Dynal As Single step method
US6492144B1 (en) * 1997-05-30 2002-12-10 Diagen Corporation Methods for detection of nucleic acid sequences in urine
US6251638B1 (en) * 1997-05-30 2001-06-26 Diagen Corporation Methods for detection of nucleic acid sequences in urine
WO2001055339A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Novel fetal nucleic acids and polypeptides
IL163600A0 (en) * 2002-03-01 2005-12-18 Ravgen Inc Methods for detection of genetic disorders
US7442506B2 (en) * 2002-05-08 2008-10-28 Ravgen, Inc. Methods for detection of genetic disorders
WO2005023091A2 (en) * 2003-09-05 2005-03-17 The Trustees Of Boston University Method for non-invasive prenatal diagnosis
US8158410B2 (en) * 2005-01-18 2012-04-17 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
US20070224597A1 (en) * 2006-03-23 2007-09-27 Biocept, Inc. Isolating fetal trophoblasts
EP3617321B1 (en) * 2006-05-31 2024-10-23 Sequenom, Inc. Kit for the extraction and amplification of nucleic acid from a sample

Also Published As

Publication number Publication date
CA2714212A1 (en) 2009-08-20
EP2242857A2 (en) 2010-10-27
CN101999003A (zh) 2011-03-30
WO2009102632A3 (en) 2009-11-26
JP2011511644A (ja) 2011-04-14
MX2010008820A (es) 2010-09-07
WO2009102632A2 (en) 2009-08-20
EP2242857A4 (en) 2011-08-17
US20110171640A1 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
BRPI0908128A2 (pt) Método para isolamento de ácido nucleicos apoptóticos ou fetais livres de células
PL2285816T5 (pl) Sposób izolacji kwasów nukleinowych
ES2626488T8 (es) Procedimientos para la síntesis de ácidos nucleicos funcionalizados
BRPI0923225A2 (pt) metodo para sintese de acidos nucleicos modificados no atomo de fosforo
BRPI0909212A2 (pt) Composições e método para sequeciamento de ácido nucléico
SMT201600475B (it) Procedimenti per la preparazione di inibitori di sglt2
GB0814570D0 (en) Isolation of nucleic acid
GB0912909D0 (en) Probes for specific analysis of nucleic acids
BRPI0920356A2 (pt) Processo para a preparação de compostos úteis como inibidores de sglt
BRPI1011936A2 (pt) métodos biológicos para a preparação de ácido adípico
BRPI0923748A2 (pt) Método para a preparação de dióis
DK2626438T3 (da) Bevarelse af føtale nukleinsyrer i maternel plasma
UY33094A (es) Procedimiento para la preparacion de dronedarona
BRPI0816258A2 (pt) processo para a preparação de compostos úteis como inibidores de sglt
PT2408562T (pt) Dispositivo microfluídico para isolamento de células
BRPI0910286A2 (pt) métodos para transformação de levedura
IT1401447B1 (it) Metodo per il trasferimento quantitativo di analiti
BRPI0908412A2 (pt) método para purificar álcool de fermentação
BRPI0817199A2 (pt) Identificaçãob e isolamento de células fetais e ácido nucleico
BRPI0924215A2 (pt) método e sistema para execução de medição
BRPI0917160A2 (pt) método para concentrar biopolímeros sensíveis ao cisalhamento
BRPI1011394A8 (pt) método para avaliação de responsividade de linforma de células b ao tratamento com anticorpos anti-cd40
EP2722388A4 (en) NUCLEIC ACID PROBE FOR THE ASSAY OF NUCLEIC ACIDS
BR112012002500A2 (pt) Processo para o preparo de derivados de ácido 1- (2-halobifenil-4-yl) - ciclopropanocarboxílico
BRPI0813788A2 (pt) Processo para preparação de metacrilato de alila

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.